dupilumab - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled syringe with needle shield
AUST R: 302463
Active ingredients:
dupilumab

Dosage form:
Injection, solution

Sponsor:
Sanofi-Aventis Australia Pty Ltd

Phone:
1800818806

From
16 Aug 2021
to
30 Nov 2021

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient

DUPIXENT dupilumab (rch) 300 mg/2 mL solution for injection pre-filled syringe with needle shield
AUST R: 283127
Active ingredients:
dupilumab

Dosage form:
Injection, solution

Sponsor:
Sanofi-Aventis Australia Pty Ltd

Phone:
1800818806

From
14 May 2021
to
30 Jul 2021

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing